A61K 9/0031
Rectum, anus
Official title: {Rectum, anus}
A61K9/0031 (Rectum, anus) appears on 820 US grants and 1,444 published applications in this corpus.
Search patents in A61K- Granted patents
- 820
- Published applications
- 1,444
- Assignees
- 664
- Inventors
- 2,233
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 4 | 0 |
| 1990 | 5 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 6 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 8 | 0 |
| 1999 | 8 | 0 |
| 2000 | 10 | 0 |
| 2001 | 12 | 0 |
| 2002 | 13 | 23 |
| 2003 | 15 | 24 |
| 2004 | 9 | 32 |
| 2005 | 5 | 26 |
| 2006 | 10 | 37 |
| 2007 | 5 | 32 |
| 2008 | 7 | 35 |
| 2009 | 6 | 32 |
| 2010 | 14 | 38 |
| 2011 | 10 | 38 |
| 2012 | 19 | 48 |
| 2013 | 23 | 44 |
| 2014 | 51 | 82 |
| 2015 | 32 | 62 |
| 2016 | 47 | 68 |
| 2017 | 46 | 75 |
| 2018 | 47 | 86 |
| 2019 | 50 | 96 |
| 2020 | 58 | 130 |
| 2021 | 54 | 98 |
| 2022 | 52 | 93 |
| 2023 | 55 | 83 |
| 2024 | 46 | 73 |
| 2025 | 39 | 49 |
| 2026 | 19 | 40 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-viral compositions and methods of making and using6 Oct 2026US 12,753,211 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Compositions for modulating gut microflora populations, enhancing drug potency and treating cancer, and methods for making and using same25 Aug 2026US 12,714,730 B2Persephone Biosciences, Inc.
- Methods and compositions for treating mucosal tissue disorders21 Jul 2026US 12,685,755 B2The University of North Carolina at Chapel Hill
- Methods and compositions for treating hemorrhoids26 May 2026US 12,636,276 B1
- Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions26 May 2026US 12,636,308 B2Adora Animal Health Corporation
- Microbial consortium and uses thereof24 Sep 2026US 2026/0284125 A1The Regents of the University of California
- Composition comprising cytidine analogs and uses and methods thereof27 Aug 2026US 2026/0248832 A1Universität Heidelberg
- Pharmaceutical dosage form for application to mucous membranes and methods for producing same20 Aug 2026US 2026/0240783 A1EsoCap AG
- Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions20 Aug 2026US 2026/0240898 A1Adora Life Science, Inc.
- Therapeutic microbiota for the treatment and/or prevention of dysbiosis20 Aug 2026US 2026/0240919 A1Children's Medical Center Corporation
Most cited
By later US patents
- Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines288US 5,635,517 ACelgene Corporation · 1997
- Probiotic recolonisation therapy240US 8,460,648 B22013
- Compositions and methods for mucosal delivery184US 6,552,024 B1Lavipharm Laboratories Inc. · 2003
- Preparation which promotes the absorption of peptides165US 4,900,730 AToyo Jozo Kabushiki Kaisha · 1990
- Controlled-release compositions containing opioid agonist and antagonist161US 6,716,449 B2Euro-Celtique S. A. · 2004